New semaglutide and cagrilintide/semaglutide results US$ 23.95 Min. order: 1 piece ★★★★★ 4.2 (296 reviews) Sold : Login>>
Novo Nordisk Aims for the Top: CagriSema Poised for Breakthrough US$ 22.88 Min. order: 1 piece ★★★★★ 4.2 (257 reviews) Sold : Login>>
CagriSema vs Tirzepatide: 23% Weight Loss in Phase 3 Trial US$ 28.84 Min. order: 1 piece ★★★★★ 4.4 (238 reviews) Sold : Login>>
Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme US$ 27.05 Min. order: 1 piece ★★★★★ 4.1 (11 reviews) Sold : Login>>
Novo Nordisk Files NDA for CagriSema, Novel GLP-1-amylin Combination for Chronic Weight Management US$ 29.56 Min. order: 1 piece ★★★★★ 4.6 (105 reviews) Sold : Login>>
Development of Cagrilintide, a Long-Acting Amylin Analogue US$ 28.84 Min. order: 1 piece ★★★★★ 4.8 (103 reviews) Sold : Login>>